Insider filing · CORT
Gary Charles Robb
Chief Business Officer
profile →
Corcept Therapeutics Incorporated
CORT · Healthcare · 106 filings in 24 months
ticker →
Gary Charles Robb sold $1.2M of Corcept Therapeutics Incorporated (CORT)
Executed Aug 17, disclosed Aug 18, 1 day later.
Value, as filed
$1.2M
10,000 sh × $116.26
Executed
Aug 17
the trade date, as filed
Disclosed
Aug 18
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
GRGary Charles Robb (Chief Business Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Corcept Therapeutics Incorporated (CORT). The largest single filing was $1.2M of CORT (10,000 sh × $116.26, as filed), executed Aug 17.
The name
CORTHealthcare · Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe end…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Gary Charles Robb in CORT
CORTSALE
Corcept Therapeutics Incorporated
$166K2,326 sh × $71.27
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $225K
3,185 sh × $70.77
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $173K
2,279 sh × $75.85
Exec May 20 2025
Filed May 22 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $556K
11,000 sh × $50.50
Exec Jan 2 2025
Filed Jan 6 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $147K
2,609 sh × $56.20
Exec Nov 22 2024
Filed Nov 26 2024 · 5:30 PM ET